Weekly Executive & Director Moves (Feb 18)

by | Feb 18, 2022

Boardroom Alpha provides in-depth analytics and tracking of all public company executives and officers. Below is a rundown of people moves made at notable companies this past week. Get a demo today to see how you can receive real-time alerts and in-depth analytics.

Highlights

Chamath Steps Down from SPCE Board, Cashes out with a Cool $300 Million

Chamath Palihapitiya stepped down as Chairman at space tourism operator Virgin Galactic (SPCE). The company says the departure is amicable. With SPCE under $9, we’re not sure shareholders would agree.

Read our full write-up on our exclusive thestreet.com channel here.

End of an era at TradeWeb

Lee Olesky, CEO of financial services company Tradeweb (TW), steps down as CEO at the operator of electronic marketplaces for rates, credit, equities and money markets, after 15 years in the role. Olesky gave the heads up early—his departure is effective December 31, 2022. William (Billy) Hult, currently President at Tradeweb Markets Inc. (TWM) will take over the role. Hult has been TWM’s President since September 2008.

William (Billy) Hult: Fresh Leadership for TradeWeb

Biocept clean sweep asCEO and CFO leave abruptly

Molecular diagnostic supplier Biocept (BIOC) made some bold changes this week. Michael W. Nall resigned from his position as the President and Chief Executive Officer, including as the principal executive officer, of Biocept and from the Company’s Board of Directors. Hall will be succeeded by Samuel D. Riccitelli as Interim President and Chief Executive Officer. Riccitelli has a strong track record of selling molecular diagnostic companies. He was previously CEO at Signal Genetics, Inc., which was sold to Miragen Therapeutics, Inc. and COO of Genoptix, Inc., which was sold to Novartis in 2011.

Timothy C. Kennedy also resigned from his position as Biocept CFO, COO and Secretary. In connection with their resignations, the Company entered into separation agreements with both Nall and Kennedy– each has agreed to provide the Company with a full release of claims. Kennedy will be succeeded by Antonino Morales as Interim CFO. Morales has over 30 years of broad leadership experience in the U.S. and Latin America and was President and CEO of Apoyo Financiero, Inc. from June 2017 to March 2020.

Moves in this Issue

CEO
ATHX, BIOC, BKI, FET, IFF, NEXI, NI, SCL, TW

CFO
ADPT, ALLE, AUMN, BIOC, CNA, ENPH, GLW, NRGV, OEC, PLD, VMC

Directors
AGLE, AME, AMWD, APPH, BCOV, BCRX, CC, CDAY, CE, CLVR, CMAX, CMPI, CTBI, DBD, DNLI, ENSC, ESE, FLR, ADP, AMD, AP, AQUA, ATHX, AVTR, AWK, BBBY, BNIX, CCI, CG, CMI, CNO, CNTA, CNVY, COWN, CYTK, DJCO, EFTR, FET, FMBI, FSP, FXLV, GWH, GWW, HBT, IFF, IHC, IMKTA, INFN, INGR, ISPO, IVR, JNJ, JSDA, KRNL, LDOS, LECO, LFVN, MAR, MHK, MMC, MSI, NEXI, NI, NMGX, NNN, NRGV, NSIT, OMF, ONB, ORGO, PAE, PAVM, POWL, PXLW, RBA, RCL, RKLY, SCL, SLDP, SMBK, SON, SPCE, SPR, SSKN, SWKH, TW, ULTA, VVNT, WPCA


CEO Moves

Athersys Inc (ATHX)
Leaving: CEO – William Lehmann Jr ( 1.0 yrs; -50.3% TSR)
Replaced by: Daniel A Camardo

Mr. Camardo, age 53, currently serves as the President, U.S., and the Executive Vice President of Horizon Therapeutics plc, a global biotechnology company, at the Rare Disease and Inflammation Business Unit and previously served as Group Vice President from September 2015 to August 2020. Before joining Horizon Therapeutics, Mr. Camardo was Vice President of Sales and Operations at Clarus Therapeut…read full bio

Biocept Inc (BIOC)
Leaving: CEO – Michael W Nall ( 9.1 yrs; -63.3% TSR)
Replaced by: Samuel D Riccitelli

Mr. Riccitelli, age 62, has served as a member of the Company’s Board since October 2020 and as Chair of the Board since June 2021. Mr. Riccitelli has been in the healthcare industry for more than 35 years. He has served as a member of the Board of Directors of Orthopediatrics, Inc. since 2017, a company focused exclusively on the orthopedic implant needs of child…read full bio

Black Knight Inc (BKI)
Leaving: CEO – M Jabbour Anthony ( 4.1 yrs; 10.2% TSR)
Replaced by: Joseph M Nackashi

Joseph M. Nackashi. Mr. Nackashi has served as our President since July 2017. Mr. Nackashi previously served as President of our Servicing Software division since January 2014, and served as our Chief Information Officer from January 2014 until June 2015. Mr. Nackashi previously served as Executive Vice President and Chief Information Officer of LPS from July 2008 until LPS was acquired by FNF in …read full bio

Forum Energy Technologies Inc (FET)
Leaving: CEO – C Christopher Gaut ( 3.3 yrs; -50.0% TSR)
Replaced by: Neal Lux

Mr. Lux, age 45, has served as the Company’s Executive Vice President and Chief Operating Officer since December 2020. Since January 2009, Mr. Lux has held various operations roles of increasing responsibility with the Company and its subsidiaries, including Executive Vice President – Operations; Senior Vice President – Completions; Managing Director – Global Tubing; and President – Global Tubing….read full bio

International Flavors & Fragrances Inc (IFF)
Leaving: CEO – Andreas Fibig ( 7.4 yrs; 6.1% TSR)
Replaced by: Frank Clyburn

Mr. Clyburn, 57, has served in various positions at Merck & Co., Inc. since 2008. Most recently, Mr. Clyburn served as the Executive Vice President and President, Human Health at Merck and a member of Merck’s Executive Committee, where he was responsible for all operations and profits and loss across the human health commercial portfolio globally. Prior to joining Merck in 2008, Mr. Clyburn served…read full bio

NexImmune Inc (NEXI)
Leaving: CEO – Scott Carmer ( 1.0 yrs; -88.3% TSR)
Replaced by: Kristi Jones

Ms. Jones, age 58, has served as the Company’s Chief Operating Officer since March 2018. She previously served as the Company’s Chief Business Officer from June 2017 to March 2018 and as a consultant to the Company from September 2015 to February 2017. From 2013 to 2015, Ms. Jones was Vice President of Portfolio Strategy at AstraZeneca. From November 2011 to July 2013 she …read full bio

Nisource Inc (NI)
Leaving: CEO – Joseph Hamrock ( 6.6 yrs; -4.2% TSR)
Replaced by: Lloyd M Yates

Mr. Yates, 61, most recently served as Executive Vice President, Customer and Delivery Operations, and President, Carolinas Region, since 2014 at Duke Energy Corporation (“Duke Energy”), until his retirement in 2019. In that role, he was responsible for aligning customer-focused products and services to deliver a personalized end-to-end customer experience to position Duke Energy for long-term gro…read full bio

Stepan Co (SCL)
Leaving: CEO – F Quinn Stepan Jr ( 16.3 yrs; 15.9% TSR)
Replaced by: Scott R Behrens

Mr. Behrens, 52, has served as President and Chief Operating Officer of the Company since January 2021. From 2014 through 2020, Mr. Behrens served as Vice President and General Manager – Surfactants of the Company. Mr. Behrens has been with the Company for nearly 30 years and during that time has served in various roles in R&D, sales and marketing. …read full bio

Tradeweb Markets Inc (TW)
Leaving: CEO – Lee Olesky ( 26.9 yrs; 31.4% TSR)
Replaced by: William Hult

(from latest proxy) Mr. Hult was selected to serve on our Board because of the perspective, management, industry experience and operational expertise in our business that he has developed as our President. Mr. Hult has served as TWM LLC’s President since September 2008 and, prior to the Reorganization Transactions, served on the former board of managers of TWM LLC beginning in September 2008…read full bio


CFO Moves

Adaptive Biotechnologies Corp (ADPT)
Leaving: CFO – Chad M Cohen ( 6.5 yrs; -31.7% TSR)
Replaced by: Kyle Piskel

Mr. Piskel, 38, has served in various roles with increasing levels of responsibility, including Corporate Controller, since joining the Company in September 2015. Prior to joining the Company, Mr. Piskel was an Accounting Manager at Expedia Group from October 2014 to August 2015. Prior to joining Expedia Group, Mr. Piskel was in the Assurance services practice at Ernst and Young, LLP from …read full bio

Allegion plc (ALLE)
Leaving: CFO – Patrick S Shannon ( 8.3 yrs; 13.8% TSR)
Replaced by: Michael J. Wagnes
Michael J. Wagnes, Vice President and General Manager, Commercial Americas, has been appointed to the position of Senior Vice President and Chief Financial Officer, effective March 1, 2022, succeeding Mr. Shannon. Mr. Wagnes, age 48, has been with Allegion and the former Ingersoll Rand (prior to Allegion’s spin in 2013) since 2006. He has been serving as Vice President and General Manager, Commerc…read full bio

Biocept Inc (BIOC)
Leaving: CFO – Timothy Kennedy ( 5.6 yrs; -61.2% TSR)
Replaced by: Antonino Morales

Mr. Morales, age 66, has served as a member of the Company’s Board since July 2021 and as a member of its Audit Committee from August 2021 until his appointment as Interim Chief Financial Officer. Mr. Morales has more than 30 years of broad leadership experience in the United States and Latin America. Mr. Morales served as President and Chief Executive Officer of Apoyo Fina…read full bio

Cna Financial Corp (CNA)
Leaving: CFO – Larry A Haefner ( .4 yrs; )
Replaced by: Scott R Lindquist
Scott most recently served as the Chief Financial Officer at Farmers Group, Inc., where he was responsible for planning, controllership, capital management, treasury, tax, actuarial, reinsurance, M&A and investments. Prior to Farmers, Scott served as Vice President and Chief Accounting Officer at Genworth Financial and Senior Vice President and Chief Accounting Officer at The Phoeni…read full bio

Corning Inc (GLW)
Leaving: CFO – R Tony Tripeny ( 6.4 yrs; 16.6% TSR)
Replaced by: Edward A Schlesinger

Mr. Schlesinger, 54, has led Corning’s corporate accounting, compliance, financial planning and analysis, shared services, and external reporting functions since 2015. He was appointed senior vice president in 2019 and became a member of the senior leadership team in 2020. He joined the company in 2013 as CFO of Corning’s Optical Communications segment. Prior to Corning, Mr. Schlesi…read full bio

Golden Minerals Co (AUMN)
Leaving: CFO – Robert P Vogels ( 12.9 yrs; -10.1% TSR)
Replaced by: Julie Weedman

Prior to joining the Company, Ms. Weedman served as Vice President Finance of Aerospace Contacts LLC from March 2020 to January 2022. Ms. Weedman also served as controller for Cupric Canyon Capital LLC from March 2015 until December 2019 and as the corporate controller of Mercator Minerals Ltd. from June 2012 to January 2015. Prior to joining Mercator, Ms. Weedman worked from 2006 to 2012 for D…read full bio

Prologis Inc (PLD)
Leaving: CFO – Thomas S Olinger ( 9.9 yrs; 20.1% TSR)
Replaced by: Timothy D. Arndt

Mr. Arndt, age 49, has served as Managing Director, Treasurer since December 31, 2013 and prior thereto held various positions with the company since joining in 2004, including as head of corporate planning and as a part of the company’s global deployment team.

Vulcan Materials CO (VMC)
Leaving: CFO – Suzanne H Wood ( 4.0 yrs; 16.8% TSR)
Replaced by: Mary Andrews Carlisle

Ms. Carlisle has served as the Company’s Vice President, Finance since March 2020. Prior to her current role, Ms. Carlisle had roles of increasing responsibility in the Company’s Finance department since 2006. In connection with Ms. Carlisle’s appointment as Senior Vice President and Chief Financial Officer, the Board approved the following elements of Ms. Carlisle’s compensation arrangement with …read full bio


Director Joins

Athersys Inc (ATHX)
Daniel A Camardo

Mr. Camardo, age 53, currently serves as the President, U.S., and the Executive Vice President of Horizon Therapeutics plc, a global biotechnology company, at the Rare Disease and Inflammation Business Unit and previously served as Group Vice President from September 2015 to August 2020. Before join…read full bio

Carlyle Group Inc (CG)
Mark S Ordan

Mr. Ordan, age 62, joined MEDNAX, Inc., a publicly-traded national medical group, in 2020 and currently serves as its Chief Executive Officer and a Director on its Board of Directors. Previously, Mr. Ordan founded and served as Chief Executive Officer of Quality Care Properties, Inc., a publicly-tra…read full bio

Carlyle Group Inc (CG)
Linda Hefner Filler

Ms. Filler, age 62, retired as President of Retail Products, Chief Marketing Officer and Chief Merchandising Officer at Walgreen Co., a retail pharmacy company, in 2017. Prior to Walgreen Co., Ms. Filler served in Executive Vice President roles at Walmart Inc., a publicly-traded retail and wholesale…read full bio

eFFECTOR Therapeutics Inc (EFTR)
Kristen Harrington-Smith

Ms. Harrington-Smith will serve as a Class I director, with an initial term expiring at the Company’s 2022 annual meeting of stockholders. Ms. Harrington-Smith has served as Senior Vice President & Chief Commercial Officer of ImmunoGen Inc., a publicly-traded clinical-stage biopharmaceutical company…read full bio

Forum Energy Technologies Inc (FET)
Neal Lux

Mr. Lux, age 45, has served as the Company’s Executive Vice President and Chief Operating Officer since December 2020. Since January 2009, Mr. Lux has held various operations roles of increasing responsibility with the Company and its subsidiaries, including Executive Vice President – Operations; Se…read full bio

Franklin Street Properties Corp (FSP)
Milton P. Wilkins, Jr

Mr. Wilkins has served as an investment advisor with RBF Wealth Advisors in St. Louis, Missouri, since 1997.  Mr. Wilkins also served concurrently from 2003 to 2015 with Hammond Associates/Mercer Investment Consulting as an institutional investment consultant.  Prior to joinin…read full bio

Insight Enterprises Inc (NSIT)
Alexander L BaumMr. Baum is a Partner of ValueAct Capital, one of the Company’s largest stockholders. He joined ValueAct in 2012 and has worked on several ValueAct IT and technology industry investments including Nintendo Co. LTD, Microsoft Corporation, and Adobe Systems, Inc among others. He has a B.A. …read full bio

Insight Enterprises Inc (NSIT)
Alexander L. Baum

Mr. Baum joined the Board pursuant to a Nomination and Cooperation Agreement (the “Agreement”), dated February 14, 2022, by and among the Company and various affiliates of ValueAct Capital (collectively, the “ValueAct Group”). The Agreement includes various terms, conditions and provisions, includin…read full bio

International Flavors & Fragrances Inc (IFF)
Frank Clyburn

Mr. Clyburn, 57, has served in various positions at Merck & Co., Inc. since 2008. Most recently, Mr. Clyburn served as the Executive Vice President and President, Human Health at Merck and a member of Merck’s Executive Committee, where he was responsible for all operations and profits and loss acros…read full bio

Lifevantage Corp (LFVN)
Cynthia Latham

Cindy currently serves as Executive Marketing Consultant at Latham Consulting Services, a strategic marketing consulting firm. She has over 30 years of experience leading global marketing, research and development, and product teams in direct selling organizations. Prior to Latham Consult…read full bio

Marriott International Inc (MAR)
Isabella D Goren

Ms. Goren will be included in the Company’s slate of nominees for election at Marriott’s 2022 Annual Meeting of Stockholders (the “2022 Annual Meeting”). Ms. Goren served as Chief Financial Officer of American Airlines, Inc. and its parent company, AMR Corporation, from 2010 through 2013. She serves…read full bio

Nano Magic Holdings Inc (NMGX)
Miles Geoffrey Gatland

 Mr Gatland is a real estate entrepreneur. He founded Miles Gatland and Associates, Inc. in 1994 and continues to be active in commercial brokerage and redevelopment. He is also an active private investor and served on the board of Surgical Safety Scanner, Inc. from November 2019 to December…read full bio

National Retail Properties Inc (NNN)
Stephen A Horn Jr

Mr. Horn’s appointment to the Board was made in connection with his previously announced transition to Chief Executive Officer and President of the Company which will be effective April 29, 2022. Mr. Horn has served as Executive Vice President and Chief Operating Officer since August 2020 and as Exe…read full bio

NexImmune Inc (NEXI)
Kristi Jones

Ms. Jones, age 58, has served as the Company’s Chief Operating Officer since March 2018. She previously served as the Company’s Chief Business Officer from June 2017 to March 2018 and as a consultant to the Company from September 2015 to February 2017. From 2013 to 2015, Ms. …read full bio

PAVmed Inc (PAVM)
Joan B. Harvey

Ms. Harvey has more than two decades of health care experience serving in a variety of leadership roles dedicated to improving whole person health and advocating for patients. She is the president of Care Solutions for Evernorth, Cigna Corporation’s (NYSE: CI) health services business. In t…read full bio

Powell Industries Inc (POWL)
John Stacey

Since 2008, Mr. Stacey has served as the Executive Vice President and Chief Human Resources Officer at Harman International Industries, a subsidiary of Samsung Electronics. Prior to joining Harman, Mr….read full bio

Rockley Photonics Holdings Ltd (RKLY)
Dr. Nicolaus Henke

Dr. Henke brings to the Board over 35 years of business experience. He has spent 30 years of his career with McKinsey & Company. In 2003, he began serving as a senior partner and led McKinsey’s healthcare practice worldwide. During his career, Dr. Henke has advised top teams in leadin…read full bio

Stepan Co (SCL)
Scott R Behrens

Mr. Behrens, 52, has served as President and Chief Operating Officer of the Company since January 2021. From 2014 through 2020, Mr. Behrens served as Vice President and General Manager – Surfactants of the Company. Mr. Behrens has been with the Company for nearly 30 years and during that ti…read full bio

SWK Holdings Corp (SWKH)
Robert K. Hatcher

Mr. Hatcher, age 59, currently serves as the Chairman of Avalon Advisors. Mr. Hatcher previously served as the President and CEO of Cockrell Interests, Pinto Investment Partners LP and Pinto Trust Company and as Chairman of the Finance Advisory Committee for PTV Healthcare Capital and Pinto Ameri…read full bio

Warburg Pincus Capital Corp I-A (WPCA)
Timothy J. Curt

Mr. Curt was a Managing Director in the Accounting and Finance Group at Warburg Pincus through December 2019, when he retired to pursue non-profit activities. Mr. Curt served as Chief Financial Officer and was a member of the Executive Management Group at Warburg Pincus from 2…read full bio


Director Exits

American Water Works Company Inc (AWK)
Lloyd M Yates ( 2.6 yrs; 13.2% TSR)
Committees: Audit, Finance and Risk, SETO

Avantor Inc (AVTR)
Rajiv Gupta ( 12.3 yrs; 32.4% TSR)
Committees: Nominating (and Governance)

Bannix Acquisition Corp (BNIX)
Kumar Shiralagi ( 1.0 yrs; -8.2% TSR)

Centessa Pharmaceuticals plc (CNTA)
Robert Califf ( .8 yrs; -66.5% TSR)

CNO Financial Group Inc (CNO)
Robert C Greving ( 11.0 yrs; 13.4% TSR)
Committees: Audit and Enterprise Risk , Executive, Investment

Convey Health Solutions Holdings Inc (CNVY)
Paul Campanelli ( .0 yrs; )

Crown Castle International Corp (CCI)
J Landis Martin ( 22.3 yrs; )
Committees: Nominating (and Governance)

Crown Castle International Corp (CCI)
J Landis Martin ( 22.3 yrs; 14.0% TSR)
Committees: Nominating (and Governance)

Cytokinetics Inc (CYTK)
Robert Califf ( 4.0 yrs; 38.3% TSR)
Committees: Science and Technology

Daily Journal Corp (DJCO)
Peter D Kaufman ( 15.4 yrs; 14.9% TSR)
Committees: Audit, Compensation

eFFECTOR Therapeutics Inc (EFTR)
Jonathan D Root ( .5 yrs; -64.7% TSR)

ESS Tech Inc (GWH)
Shirley Speakman ( .3 yrs; )

Evoqua Water Technologies Corp (AQUA)
Judd A Gregg ( 7.9 yrs; 17.3% TSR)
Committees: Compensation, Nominating (and Governance)

F45 Training Holdings Inc (FXLV)
Ruth Zukerman ( .6 yrs; -22.4% TSR)

Infinera Corp (INFN)
Hooshmand Kambiz ( 12.2 yrs; .5% TSR)
Committees: Audit, Nominating (and Governance), Technology and Acquisition

Infinera Corp (INFN)
Thomas J Fallon ( 12.6 yrs; -1.1% TSR)

Infinera Corp (INFN)
Marcel Gani ( 8.0 yrs; -.6% TSR)
Committees: Audit, Compensation

Infinera Corp (INFN)
Mark A Wegleitner ( 11.0 yrs; .1% TSR)
Committees: Nominating (and Governance), Technology and Acquisition

Ingles Markets Inc (IMKTA)
Ronald B Freeman ( 16.8 yrs; 14.6% TSR)
Committees: Executive

Ingredion Inc (INGR)
Barbara A Klein ( 17.9 yrs; 11.4% TSR)
Committees: Compensation, People, Culture and Compensation

International Flavors & Fragrances Inc (IFF)
Edward D Breen ( 2.0 yrs; 3.5% TSR)
Committees: Nominating (and Governance)

International Flavors & Fragrances Inc (IFF)
Andreas Fibig ( 11.1 yrs; 10.5% TSR)
Committees: Innovation and Sustainability

Jones Soda Co (JSDA)
Mick Fleming ( 24.8 yrs; -1.3% TSR)
Committees: Audit, Compensation and Governance, Nominating (and Governance)

Jones Soda Co (JSDA)
Jeffrey D Anderson ( 4.5 yrs; 3.2% TSR)
Committees: Audit, Compensation, Compensation and Governance, Nominating (and Governance)

Kernel Group Holdings Inc (KRNL)
Rakesh Tondon ( 1.1 yrs; -6.4% TSR)

Marriott International Inc (MAR)
J W Marriott Jr ( 58.3 yrs; 12.3% TSR)
Committees: Executive Committee

Marriott International Inc (MAR)
Lawrence W Kellner ( 20.3 yrs; 12.6% TSR)
Committees: Executive Committee, Nominating (and Governance)

NexImmune Inc (NEXI)
Scott Carmer ( 1.0 yrs; -88.3% TSR)

Nisource Inc (NI)
Joseph Hamrock ( 7.1 yrs; -2.3% TSR)

Old National Bancorp (ONB)
Randall T Shepard ( 9.6 yrs; 8.6% TSR)
Committees: Culture, Community and Social Responsibility, Enterprise Risk, Nominating (and Governance), Talent Development and Compensation

Old National Bancorp (ONB)
Jerome F Henry Jr ( 7.7 yrs; 7.4% TSR)
Committees: Audit, Funds Management

Old National Bancorp (ONB)
Phelps L Lambert ( 32.1 yrs; 1.5% TSR)
Committees: Audit, Finance and Corporate Development, Funds Management , Nominating (and Governance)

Old National Bancorp (ONB)
Linda Elaine White ( 6.5 yrs; 7.3% TSR)
Committees: Culture, Community and Social Responsibility, Enterprise Risk, Finance and Corporate Development

Old National Bancorp (ONB)
Andrew E Goebel ( 22.1 yrs; 1.5% TSR)
Committees: Audit, Enterprise Risk, Finance and Corporate Development, Funds Management

Pixelworks Inc (PXLW)
Richard L Sanquini ( 12.3 yrs; .5% TSR)
Committees: Audit, Compensation

Ritchie Bros Auctioneers Inc (RBA)
Beverley Anne Briscoe ( 17.5 yrs; 13.4% TSR)
Committees: Audit, Nominating (and Governance)

Sonoco Products Co (SON)
Marc D Oken ( 16.2 yrs; 7.5% TSR)
Committees: Audit, Compensation, Executive, Executive Compensation, Nominating (and Governance)

Sonoco Products Co (SON)
Lloyd M Yates ( 2.4 yrs; 2.2% TSR)
Committees: Audit, Employee and Public Responsibility

Tradeweb Markets Inc (TW)
Martin Brand ( 2.9 yrs; 31.4% TSR)
Committees: Compensation, Nominating (and Governance)

Virgin Galactic Holdings Inc (SPCE)
Chamath Palihapitiya ( 4.8 yrs; -2.8% TSR)

Vivint Smart Home Inc (VVNT)
Bruce McEvoy ( 2.1 yrs; -17.4% TSR)
Committees: Compensation

Ww Grainger Inc (GWW)
Brian P Anderson ( 23.3 yrs; 13.2% TSR)
Committees: Audit, Board Affairs & Nominating Committee

<a href="https://www.boardroomalpha.com/author/joanna/" target="_self">Joanna Makris</a>

Joanna Makris

Joanna has been analyzing and investing in emerging technologies for over two decades, having led the Technology, Media, and Telecom research at several global investment banks, including Mizuho Securities and Canaccord Genuity. Navigating stock market volatility since it all began in 2000. Banjo player, artist, and frittata-maker.

More from Boardroom Alpha

Target’s Bloodbath

Target had its worst day since the Black Monday crash in 1987. With inflation proving to be a slow-moving illness, governance and execution will be key for retail stocks.

Starting the Week with 2 DAs

Starting the week off with 2 DAs– oil & gas and battery tech. And the rest of the day’s news in SPACs.

Home Depot: Bad News Looks Baked-In

In a big week for retail earnings reports, we take a closer look at HD fundamentals and governance. Bottom line: don’t hate on HD into the Q1 print: the bar is set low, and long-term fundamentals look good.

Comera Gets Approval, with Over 98% Redemptions

Squeeze alert: OTRA approves its merger with Comera Life Sciences, albeit with some of highest redemptions we’ve seen in a while (98.4%). And the rest of the day’s news in SPACs.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed. 

Executive Moves

Newsletter

Get it in your inbox weekly and don't miss a move